Physician profile
Jennifer M Moller
NPI 1487081097
$1,504.77
in general payments reported to CMS, 2019-2025
18 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $491 · 2023: $207 · 2024: $287 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $195.94 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $144.93 | 2021-2024 | Winlevi |
| Genzyme Corporation | $143.05 | 2021-2024 | |
| Galderma Laboratories, L.P. | $131.50 | 2021-2022 | |
| Incyte Corporation | $127.65 | 2022-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $113.98 | 2022-2024 | Dupixent |
| Amgen INC. | $112.58 | 2021-2024 | Otezla |
| Biofrontera INC. | $102.94 | 2022-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Revance Therapeutics, INC. | $89.12 | 2025 | Daxxify |
| Janssen Biotech, INC. | $77.74 | 2025 | Tremfya |
| Pfizer INC. | $50.95 | 2023 | |
| Allergan, INC. | $39.83 | 2022 | |
| Exact Sciences Corporation | $34.15 | 2025 | The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $32.20 | 2025 | Symbravo |
| Bayer Healthcare Pharmaceuticals INC. | $31.16 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $27.19 | 2025 | |
| Hologic Sales and Service, LLC | $26.32 | 2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Abbvie INC. | $23.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Moller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.